ROCHE HOLDING AG-BR (RHO.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:RHO - CH0012032113 - Common Stock
350 EUR
+2.8 (+0.81%)
RHO gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 55 industry peers in the Pharmaceuticals industry. While RHO belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. RHO has a valuation in line with the averages, but on the other hand it scores bad on growth.
1. Profitability
1.1 Basic Checks
RHO had positive earnings in the past year.
In the past year RHO had a positive cash flow from operations.
RHO had positive earnings in each of the past 5 years.
Each year in the past 5 years RHO had a positive operating cash flow.
1.2 Ratios
Looking at the Return On Assets, with a value of 9.95%, RHO is in the better half of the industry, outperforming 71.43% of the companies in the same industry.
RHO has a Return On Equity of 32.88%. This is amongst the best in the industry. RHO outperforms 83.93% of its industry peers.
RHO has a Return On Invested Capital of 24.24%. This is amongst the best in the industry. RHO outperforms 91.07% of its industry peers.
The Average Return On Invested Capital over the past 3 years for RHO is significantly above the industry average of 14.51%.
The last Return On Invested Capital (24.24%) for RHO is above the 3 year average (23.72%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.95% | ||
| ROE | 32.88% | ||
| ROIC | 24.24% |
ROA(3y)11.64%
ROA(5y)13.32%
ROE(3y)36.55%
ROE(5y)41.17%
ROIC(3y)23.72%
ROIC(5y)23.71%
1.3 Margins
The Profit Margin of RHO (15.31%) is comparable to the rest of the industry.
RHO's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 33.79%, RHO belongs to the top of the industry, outperforming 85.71% of the companies in the same industry.
In the last couple of years the Operating Margin of RHO has remained more or less at the same level.
RHO's Gross Margin of 73.92% is fine compared to the rest of the industry. RHO outperforms 66.07% of its industry peers.
RHO's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 33.79% | ||
| PM (TTM) | 15.31% | ||
| GM | 73.92% |
OM growth 3Y4.01%
OM growth 5Y0.18%
PM growth 3Y-14.88%
PM growth 5Y-9.03%
GM growth 3Y2.22%
GM growth 5Y0.6%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), RHO is creating value.
The number of shares outstanding for RHO has been reduced compared to 1 year ago.
The number of shares outstanding for RHO has been reduced compared to 5 years ago.
The debt/assets ratio for RHO is higher compared to a year ago.
2.2 Solvency
RHO has an Altman-Z score of 4.50. This indicates that RHO is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of RHO (4.50) is better than 66.07% of its industry peers.
RHO has a debt to FCF ratio of 2.50. This is a good value and a sign of high solvency as RHO would need 2.50 years to pay back of all of its debts.
RHO has a Debt to FCF ratio of 2.50. This is in the better half of the industry: RHO outperforms 69.64% of its industry peers.
A Debt/Equity ratio of 1.06 is on the high side and indicates that RHO has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 1.06, RHO is doing worse than 69.64% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.06 | ||
| Debt/FCF | 2.5 | ||
| Altman-Z | 4.5 |
ROIC/WACC5.13
WACC4.73%
2.3 Liquidity
A Current Ratio of 1.29 indicates that RHO should not have too much problems paying its short term obligations.
RHO has a Current ratio of 1.29. This is comparable to the rest of the industry: RHO outperforms 48.21% of its industry peers.
RHO has a Quick Ratio of 1.02. This is a normal value and indicates that RHO is financially healthy and should not expect problems in meeting its short term obligations.
RHO has a Quick ratio of 1.02. This is in the better half of the industry: RHO outperforms 60.71% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.29 | ||
| Quick Ratio | 1.02 |
3. Growth
3.1 Past
The Earnings Per Share has been growing slightly by 5.19% over the past year.
RHO shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -1.39% yearly.
RHO shows a small growth in Revenue. In the last year, the Revenue has grown by 4.77%.
The Revenue has been decreasing by -0.32% on average over the past years.
EPS 1Y (TTM)5.19%
EPS 3Y-1.73%
EPS 5Y-1.39%
EPS Q2Q%8.5%
Revenue 1Y (TTM)4.77%
Revenue growth 3Y-1.24%
Revenue growth 5Y-0.32%
Sales Q2Q%3.67%
3.2 Future
RHO is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 6.39% yearly.
Based on estimates for the next years, RHO will show a small growth in Revenue. The Revenue will grow by 3.51% on average per year.
EPS Next Y5.57%
EPS Next 2Y5.21%
EPS Next 3Y5.44%
EPS Next 5Y6.39%
Revenue Next Year2.13%
Revenue Next 2Y2.43%
Revenue Next 3Y2.75%
Revenue Next 5Y3.51%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 16.53, which indicates a correct valuation of RHO.
60.71% of the companies in the same industry are more expensive than RHO, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 25.45. RHO is valued slightly cheaper when compared to this.
The Price/Forward Earnings ratio is 15.62, which indicates a correct valuation of RHO.
RHO's Price/Forward Earnings is on the same level as the industry average.
RHO is valuated cheaply when we compare the Price/Forward Earnings ratio to 34.46, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.53 | ||
| Fwd PE | 15.62 |
4.2 Price Multiples
RHO's Enterprise Value to EBITDA ratio is in line with the industry average.
64.29% of the companies in the same industry are more expensive than RHO, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 19.93 | ||
| EV/EBITDA | 12.21 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The excellent profitability rating of RHO may justify a higher PE ratio.
PEG (NY)2.96
PEG (5Y)N/A
EPS Next 2Y5.21%
EPS Next 3Y5.44%
5. Dividend
5.1 Amount
RHO has a Yearly Dividend Yield of 3.11%. Purely for dividend investing, there may be better candidates out there.
RHO's Dividend Yield is a higher than the industry average which is at 2.96.
RHO's Dividend Yield is a higher than the S&P500 average which is at 2.42.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.11% |
5.2 History
The dividend of RHO has a limited annual growth rate of 2.37%.
Dividend Growth(5Y)2.37%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
85.87% of the earnings are spent on dividend by RHO. This is not a sustainable payout ratio.
The dividend of RHO is growing, but earnings are growing more, so the dividend growth is sustainable.
DP85.87%
EPS Next 2Y5.21%
EPS Next 3Y5.44%
FRA:RHO (11/21/2025, 7:00:00 PM)
350
+2.8 (+0.81%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners40.11%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap283.24B
Revenue(TTM)61.59B
Net Income(TTM)9.43B
Analysts70.37
Price Target349.07 (-0.27%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.11% |
Yearly Dividend10.87
Dividend Growth(5Y)2.37%
DP85.87%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.61%
PT rev (3m)2.43%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-0.45%
EPS NY rev (3m)-1.56%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.31%
Revenue NY rev (3m)-0.85%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.53 | ||
| Fwd PE | 15.62 | ||
| P/S | 4.27 | ||
| P/FCF | 19.93 | ||
| P/OCF | 13.65 | ||
| P/B | 9.17 | ||
| P/tB | 60.54 | ||
| EV/EBITDA | 12.21 |
EPS(TTM)21.18
EY6.05%
EPS(NY)22.4
Fwd EY6.4%
FCF(TTM)17.56
FCFY5.02%
OCF(TTM)25.65
OCFY7.33%
SpS81.93
BVpS38.15
TBVpS5.78
PEG (NY)2.96
PEG (5Y)N/A
Graham Number134.84
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.95% | ||
| ROE | 32.88% | ||
| ROCE | 30.98% | ||
| ROIC | 24.24% | ||
| ROICexc | 24.24% | ||
| ROICexgc | 36.85% | ||
| OM | 33.79% | ||
| PM (TTM) | 15.31% | ||
| GM | 73.92% | ||
| FCFM | 21.43% |
ROA(3y)11.64%
ROA(5y)13.32%
ROE(3y)36.55%
ROE(5y)41.17%
ROIC(3y)23.72%
ROIC(5y)23.71%
ROICexc(3y)28.94%
ROICexc(5y)29.11%
ROICexgc(3y)49.53%
ROICexgc(5y)49.86%
ROCE(3y)29.26%
ROCE(5y)30.68%
ROICexgc growth 3Y2.54%
ROICexgc growth 5Y-3.21%
ROICexc growth 3Y1.27%
ROICexc growth 5Y-3.5%
OM growth 3Y4.01%
OM growth 5Y0.18%
PM growth 3Y-14.88%
PM growth 5Y-9.03%
GM growth 3Y2.22%
GM growth 5Y0.6%
F-Score8
Asset Turnover0.65
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.06 | ||
| Debt/FCF | 2.5 | ||
| Debt/EBITDA | 1.27 | ||
| Cap/Depr | 195% | ||
| Cap/Sales | 9.87% | ||
| Interest Coverage | 17.17 | ||
| Cash Conversion | 80.58% | ||
| Profit Quality | 140.01% | ||
| Current Ratio | 1.29 | ||
| Quick Ratio | 1.02 | ||
| Altman-Z | 4.5 |
F-Score8
WACC4.73%
ROIC/WACC5.13
Cap/Depr(3y)132.99%
Cap/Depr(5y)129.62%
Cap/Sales(3y)7.8%
Cap/Sales(5y)8.42%
Profit Quality(3y)129.49%
Profit Quality(5y)117.9%
High Growth Momentum
Growth
EPS 1Y (TTM)5.19%
EPS 3Y-1.73%
EPS 5Y-1.39%
EPS Q2Q%8.5%
EPS Next Y5.57%
EPS Next 2Y5.21%
EPS Next 3Y5.44%
EPS Next 5Y6.39%
Revenue 1Y (TTM)4.77%
Revenue growth 3Y-1.24%
Revenue growth 5Y-0.32%
Sales Q2Q%3.67%
Revenue Next Year2.13%
Revenue Next 2Y2.43%
Revenue Next 3Y2.75%
Revenue Next 5Y3.51%
EBIT growth 1Y10.03%
EBIT growth 3Y2.72%
EBIT growth 5Y-0.14%
EBIT Next Year25.3%
EBIT Next 3Y10.44%
EBIT Next 5Y9.08%
FCF growth 1Y12.91%
FCF growth 3Y-2.8%
FCF growth 5Y-2.91%
OCF growth 1Y19.07%
OCF growth 3Y-1.42%
OCF growth 5Y-2.14%
ROCHE HOLDING AG-BR / RHO.DE FAQ
Can you provide the ChartMill fundamental rating for ROCHE HOLDING AG-BR?
ChartMill assigns a fundamental rating of 6 / 10 to RHO.DE.
Can you provide the valuation status for ROCHE HOLDING AG-BR?
ChartMill assigns a valuation rating of 5 / 10 to ROCHE HOLDING AG-BR (RHO.DE). This can be considered as Fairly Valued.
How profitable is ROCHE HOLDING AG-BR (RHO.DE) stock?
ROCHE HOLDING AG-BR (RHO.DE) has a profitability rating of 8 / 10.
What is the expected EPS growth for ROCHE HOLDING AG-BR (RHO.DE) stock?
The Earnings per Share (EPS) of ROCHE HOLDING AG-BR (RHO.DE) is expected to grow by 5.57% in the next year.
How sustainable is the dividend of ROCHE HOLDING AG-BR (RHO.DE) stock?
The dividend rating of ROCHE HOLDING AG-BR (RHO.DE) is 4 / 10 and the dividend payout ratio is 85.87%.